← Back
$URGN All transactions

UroGen Pharma Ltd.

A

$ Value

$0

Shares

32,609

Price

$0

Filed

Feb 3

Insider

Name

Degnan Chris

Title

Chief Financial Officer

CIK

0001741968

Roles

Officer

Transaction Details

Transaction Date

2026-01-31

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

32,609

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. | 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029.

Filing Info

Accession No.

0001437749-26-002841

Form Type

4

Issuer CIK

0001668243

Degnan Chris's History

Date Ticker Type Value
2026-01-31 URGN A $0
2025-10-08 URGN M
2025-10-08 URGN $37K
2025-10-08 URGN M $0

Other Insiders at URGN (90d)

Insider Bought Sold Last
Robinson James A. Jr. 2025-02-26
Schoenberg Mark
Chief Medical Officer
$145K 2026-02-03
Barrett Elizabeth A.
Chief Executive Officer
2026-01-31
Smith Jason Drew
General Counsel
$147K 2026-02-03